These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 25965695)

  • 1. Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice.
    Kjær TN; Thorsen K; Jessen N; Stenderup K; Pedersen SB
    PLoS One; 2015; 10(5):e0126599. PubMed ID: 25965695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
    Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
    Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
    Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
    Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
    Morimura S; Oka T; Sugaya M; Sato S
    J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
    Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
    Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines.
    Dou R; Liu Z; Yuan X; Xiangfei D; Bai R; Bi Z; Yang P; Yang Y; Dong Y; Su W; Li D; Mao C
    PLoS One; 2017; 12(5):e0176823. PubMed ID: 28464025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
    Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
    Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
    J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
    OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
    Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
    Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
    Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
    Shi Q; He Q; Chen W; Long J; Zhang B
    J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.
    Chorachoo J; Lambert S; Furnholm T; Roberts L; Reingold L; Auepemkiate S; Voravuthikunchai SP; Johnston A
    PLoS One; 2018; 13(10):e0205340. PubMed ID: 30321197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
    Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
    Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
    J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
    Sun J; Zhao Y; Hu J
    PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.